`
`
`
`
`
`
`Kenneth L. Dorsney
`302.888.6855
`kdorsney@morrisjames.com
`
`
`
`
`
`
`
`
`
`
`
`October 29, 2019
`
`
`
`
`VIA CM/ECF AND HAND DELIVERY
`The Honorable Leonard P. Stark
`United States District Court for the District of Delaware
`844 N. King Street
`Wilmington, DE 19801
`
`
`
`
`
`
`
`
`Re: Bayer Healthcare LLC v. Apotex Inc., et al.,
`
`C.A. No. 16-1221-LPS (Consolidated)
`
`
`Dear Chief Judge Stark:
`
`
`We jointly submit this letter on behalf of all parties in the above-referenced matter. We
`are aware of the Court’s heavy docket and recent orders setting trials in other matters during the
`November 18 week that the parties in this matter are scheduled to go to trial. To that end, we
`respectfully ask whether it is appropriate to inform witnesses, experts, and other trial personnel
`that trial will not proceed during that period so that they may make appropriate travel and other
`arrangements. This is a case in which Apotex has filed a Paragraph III certification to a blocking
`patent that is listed in the Orange Book and does not expire until June 28, 2022. We are
`available at the Court’s convenience to discuss rescheduling.
`
`Respectfully,
`
`Kenneth L. Dorsney
`
`Kenneth L. Dorsney (I.D. #3726)
`
`All counsel of record (via e-filing and email)
`
`
`cc:
`
`
`
`
`
`T 302.888.6800
`F 302.571.1750
`500 Delaware Avenue, Suite 1500
`| Wilmington, DE 19801-1494
`Mailing Address P.O. Box 2306 | Wilmington, DE 19899-2306 www.morrisjames.com
`
`11332710/1
`
`